Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Ph…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Corvus Pharmaceuticals, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Corvus Pharmaceuticals, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Corvus Pharmaceuticals, Inc..